[Analysis of severe liver injury in a patient treated with oxaliplatin, capecitabine, and a PD-1 inhibitor: a case report].

Wang, D; Li, X; Jin, J L; Hu, Y L; Wang, C

Wang, D; Li, X; Jin, J L; Hu, Y L; Wang, C.

Afiliación

Wang D; Department of Hepatology, Center of Infectious Diseases and Pathogen Biology, the First Hospital of Jilin University, Changchun 130021, China.
Li X; Department of Hepatology, Center of Infectious Diseases and Pathogen Biology, the First Hospital of Jilin University, Changchun 130021, China.
Jin JL; Department of Hepatology, Center of Infectious Diseases and Pathogen Biology, the First Hospital of Jilin University, Changchun 130021, China.
Hu YL; Department of Hepatology, Center of Infectious Diseases and Pathogen Biology, the First Hospital of Jilin University, Changchun 130021, China.
Wang C; Department of Hepatology, Center of Infectious Diseases and Pathogen Biology, the First Hospital of Jilin University, Changchun 130021, China.

Zhonghua Gan Zang Bing Za Zhi ; 31(12): 1329-1331, 2023 Dec 20.

Article en Zh | MEDLINE | ID: mdl-38253079

Asunto(s)

Inhibidores de Puntos de Control Inmunológico; Humanos; Capecitabina/efectos adversos; Oxaliplatino/efectos adversos

Palabras clave

Immune-related hepatitis; Immunomodulation; PD-1 inhibitor

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de Puntos de Control Inmunológico Límite: Humans Idioma: Zh Revista: Zhonghua Gan Zang Bing Za Zhi Asunto de la revista: GASTROENTEROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google